Diferentes modelos para avaliar a relação custo-efetividade de inibidores de tirosina quinase do EGFR no tratamento do câncer de pulmão não pequenas células metastático no contexto do Sistema Único de Saúde

Translated title of the contribution: Distinct models to assess the cost-effectiveness of egfr-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian unified health care system

Pedro Aguiar, Felipe Roitberg, Gilberto Lopes, Auro del Giglio

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Distinct models to assess the cost-effectiveness of egfr-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian unified health care system'. Together they form a unique fingerprint.

Medicine & Life Sciences